Ubiquinol is an investigational drug.
There have been 13 clinical trials for Ubiquinol.
The most recent clinical trial was a Phase 3 trial, which was initiated on August 1st 2017.
The most common disease conditions in clinical trials are Heart Failure, Mitochondrial Diseases, and Fatigue. The leading clinical trial sponsors are Beth Israel Deaconess Medical Center, Kaneka Medical America LLC, and Kaneka Pharma America LLC.
There are five hundred and seven US patents protecting this investigational drug and five international patents.